Twitter | Search | |
ben goldacre
Doctor, nerd cheerleader, Bad Science person, stats geek, procrastinator. I run at making tools+papers from data ben@badscience.net
66,473
Tweets
2,916
Following
482,279
Followers
Tweets
ben goldacre 7m
This is fabulous work. We will blog shortly!
Reply Retweet Like
ben goldacre retweeted
Chris Winchester Feb 20
“Patients and policymakers will reasonably wonder why German academics are stating they will ignore EU reporting requirements, while German pharmaceutical companies are readily and energetically complying,” say et al in .
Reply Retweet Like
ben goldacre Feb 20
Doug Altman scholarship, phase one.
Reply Retweet Like
ben goldacre retweeted
ben goldacre Feb 14
Replying to @COMPare_Trials
We sent correction letters on every misreported clinical trial in the world's biggest medical journals, to see how the editors - and the trialists - would react. What happened next? ...
Reply Retweet Like
ben goldacre Feb 20
M bb
Reply Retweet Like
ben goldacre retweeted
Triin Edovald Feb 20
A new paper by about poor trial outcome reporting - uses a neat design to reveal authors' and top journals' apparent lack of concern / understanding about the problem
Reply Retweet Like
ben goldacre Feb 19
Shamima Begum losing citizenship as enemy of the state has got me watching Diana Mitford (married Mosley in Goebbels' front room, interned, etc) on YouTube. Everyone is so fascinatingly lovely and deferential to her while she's kind, in turn, about Hitler
Reply Retweet Like
ben goldacre Feb 19
"Complex social process overall doesn't deliver stated goals" I can cope with. But post-COMPare I still feel I just don't understand journals' *intentions* wrt to CONSORT. Why endorse reporting standards if you don't implement them, or engage positively when notified of breaches?
Reply Retweet Like
ben goldacre Feb 19
Good piece. I know many academic journal editors do great work but I struggle when they present themselves, as a class, in opposition to "lay" "journalists"... because we know that academic journal editors often do not implement the rules they espouse:
Reply Retweet Like
ben goldacre Feb 19
The problems run deep. As our recent papers on COMPare show: when you notify editors that trials have been misreported on their pages, and breached the CONSORT guidelines - which the journal endorses - those editors often do not respond constructively.
Reply Retweet Like
ben goldacre Feb 19
Oh interesting. New entrants didn't bring down the price of TNF inhibitors, they seem to have pushed prices up. Increased willingness to pay, increased perception of value for whole class? Anyway: interesting data for those who assume competition within class drives prices down.
Reply Retweet Like
ben goldacre Feb 19
I've annotated the official announcement for the new NHSX to make it more human-readable.
Reply Retweet Like
ben goldacre retweeted
EASE Feb 19
New on our blog, commentary on 's paper in Nature Trials, which looks at understanding why trial outcome misreporting persists despite strong commitments to address it.
Reply Retweet Like
ben goldacre Feb 19
Reply Retweet Like
ben goldacre retweeted
EUPATI_CH Feb 18
So pleased to see the BMJ's "unreported trial of the week" back on the radar. Keep it coming, ! We want in research and accountability to . Keeping
Reply Retweet Like
ben goldacre retweeted
Iain Chalmers Feb 18
The James Lind Initiative is closing at the end of next month. Here's an account of our efforts over the past 16 years to promote critical thinking among patients and professionals about treatment effects claims
Reply Retweet Like
ben goldacre Feb 18
ah ok thnks
Reply Retweet Like
ben goldacre retweeted
CEBM Feb 18
Publications from and currently hold the top three Altmetric Attention Scores in Trials this month!
Reply Retweet Like
ben goldacre Feb 18
On mobile I didn't see at a glance a single image example in that link?
Reply Retweet Like
ben goldacre Feb 18
Replying to @deevybee
Mm, that's kind of bee swarm plus kernel density.
Reply Retweet Like